These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 8338815)

  • 1. Quantitation of HLA class II antigens on B-cell lines.
    Bux J; Spengel U; Mueller-Eckhardt G
    Eur J Immunogenet; 1993 Jun; 20(3):189-92. PubMed ID: 8338815
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Monoclonal antibodies to HLA-DP, DQ, and DR determinants: functional effects on the activation and proliferation of normal and EBV-transformed B cells.
    Howard DR; Eaves AC; Takei F
    Exp Hematol; 1986 Oct; 14(9):887-95. PubMed ID: 2428652
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Monoclonal antibodies to sheep MHC class II molecules recognize all HLA-D or subsets of HLA-D region products.
    Puri NK; de Kretser T; Brandon MR
    Hum Immunol; 1987 Nov; 20(3):195-207. PubMed ID: 3501780
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of HLA class I and class II antigens in activation and differentiation of B cells.
    Giudizi MG; Biagiotti R; Almerigogna F; Alessi A; Tiri A; Del Prete GF; Ferrone S; Romagnani S
    Cell Immunol; 1987 Aug; 108(1):97-108. PubMed ID: 3111726
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Monoclonal antibodies that distinguish between class II antigens (HLA-DP, DQ, and DR) in 14 haplotypes.
    Robbins PA; Evans EL; Ding AH; Warner NL; Brodsky FM
    Hum Immunol; 1987 Apr; 18(4):301-13. PubMed ID: 3494718
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular characterization of major histocompatibility complex class II gene expression and demonstration of antigen-specific T cell response indicate a new phenotype in class II-deficient patients.
    Hauber I; Gulle H; Wolf HM; Maris M; Eggenbauer H; Eibl MM
    J Exp Med; 1995 Apr; 181(4):1411-23. PubMed ID: 7699327
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression and function of class II antigens on gastric carcinoma cells and gastric epithelia: differential expression of DR, DQ, and DP antigens.
    Sakai K; Takiguchi M; Mori S; Kobori O; Morioka Y; Inoko H; Sekiguchi M; Kano K
    J Natl Cancer Inst; 1987 Nov; 79(5):923-32. PubMed ID: 2960847
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential expression of HLA-DR, -DQ, and -DP antigens on malignant B cells.
    Pesando JM; Graf L
    J Immunol; 1986 Jun; 136(11):4311-8. PubMed ID: 2939141
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of seven new monoclonal antibodies against human DR, DR + DP and DQ1 + DQ3 antigens.
    Horejsí V; Nĕmec M; Angelisová P; Kristofová H; Gorga JC; Hilgert I
    Tissue Antigens; 1986 Nov; 28(5):288-97. PubMed ID: 2435017
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A ligand-epitope in vitro analysis of major histocompatibility determinants expressed on B and T lymphocytes.
    Fernandez N; Kurpisz M; Labeta M; Sachs J; Pawelec G
    Immunology; 1992 Sep; 77(1):116-22. PubMed ID: 1383136
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A preliminary analysis of the 11th International Histocompatibility Workshop monoclonal antibodies.
    Marsh SG; Krausa P; Bodmer JG
    Tissue Antigens; 1990 Oct; 36(4):180-6. PubMed ID: 2077674
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Complexity of the supertypic HLA-DRw53 specificity: two distinct epitopes differentially expressed on one or all of the DR beta-chains depending on the HLA-DR allotype.
    Knowles RW; Flomenberg N; Horibe K; Winchester R; Radka SF; Dupont B
    J Immunol; 1986 Oct; 137(8):2618-26. PubMed ID: 2428870
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel HLA class II molecule (DR alpha-DQ beta) created by mismatched isotype pairing.
    Lotteau V; Teyton L; Burroughs D; Charron D
    Nature; 1987 Sep 24-30; 329(6137):339-41. PubMed ID: 3306409
    [TBL] [Abstract][Full Text] [Related]  

  • 14. T cells specific for different antigens express different HLA-D region products.
    Schendel DJ; Johnson JP
    Eur J Immunol; 1985 Dec; 15(12):1239-43. PubMed ID: 3878791
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Autologous B lymphoblastoid cell lines and long-term cultured T cells as stimulators in the mixed lymphocyte reaction: analysis of the role of HLA class II antigens as stimulatory molecules.
    Santoli D; Radka SF; Igarashi M; Kreider BL; Ferrone S
    J Immunol; 1986 Jul; 137(2):400-7. PubMed ID: 2941479
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HLA class II DNA typing using ocular tissue and its usefulness in corneal transplantation.
    Munkhbat B; Hagihara M; Sato T; Tsuchida F; Shimazaki J; Tsubota K; Tsuji K
    Transplant Proc; 1996 Jun; 28(3):1257-8. PubMed ID: 8658648
    [No Abstract]   [Full Text] [Related]  

  • 17. Evidence for chemical differences in HLA-DR molecules on autologous acute lymphoblastic leukemia and B-lymphoblastoid cell lines.
    Graf L; Pesando JM
    Blood; 1987 Jan; 69(1):7-11. PubMed ID: 3491643
    [TBL] [Abstract][Full Text] [Related]  

  • 18. B-cell lymphomas of high-grade malignancy frequently lack HLA-DR, -DP and -DQ antigens and associated invariant chain.
    Momburg F; Herrmann B; Moldenhauer G; Möller P
    Int J Cancer; 1987 Nov; 40(5):598-603. PubMed ID: 3316049
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential expression of HLA class II antigens in fetal human spleen: relationship of HLA-DP, DQ, and DR to immunoglobulin expression.
    Edwards JA; Durant BM; Jones DB; Evans PR; Smith JL
    J Immunol; 1986 Jul; 137(2):490-7. PubMed ID: 3522732
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection of HLA-DP serological allodeterminants by the use of radioiodinated DP molecules.
    Tanigaki N; Tosi R; Parodi B; Sorrentino R; Ferrara GB; Strominger JL
    Eur J Immunol; 1987 Jun; 17(6):743-50. PubMed ID: 2439347
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.